Choosing antithrombotics for atrial fibrillation in primary care
Atrial fibrillation (AF) is the most common cardiac arrhythmia in the UK affecting 1.3 million people. AF is particularly common in older people, with one in ten over the age of 75 years affected. The prevalence of AF is projected to increase with improved survival of patients from chronic cardiac d...
Asıl Yazarlar: | Mustafa, M, Sheppard, JP |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Royal College of General Practictioners
2020
|
Benzer Materyaller
-
Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?
Yazar:: E V Schlyakhto, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01) -
Dual antithrombotic therapy and gastroprotection in atrial fibrillation: an observational primary care study
Yazar:: Charis Xuan Xie, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01) -
ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
Yazar:: A. Y. Rychkov, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01) -
Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
Yazar:: V. I. Petrov, ve diğerleri
Baskı/Yayın Bilgisi: (2019-03-01) -
APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
Yazar:: E. A. Ushkalova, ve diğerleri
Baskı/Yayın Bilgisi: (2017-05-01)